G
WGS
GeneDx Holdings Corp
101.10
-3.85-3.67%After Hours: 101.10 0.00 0.00%19:30 09/18 EDT
OPEN/PREV CLOSE70.31/71.52
TODAY RANGE70.26-71.43
VOL15.52K
MARKET CAP2.10B
52 WEEK RANGE32.21-170.87
AVG VOL (3M)727.02K
% TURNOVER0.05%
TURNOVER--
P/E (TTM)-19.4422
% RANGE1.64%
EPS(TTM)-3.6287
P/E(FORWARD)-21.0283
P/B8.61
BVPS8.19
DIVIDEND--
P/S4.826
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.94B
SHARES OUTSTANDING29.82M
NEXT EARNINGS10/26-10/30
FREE FLOAT27.52M
LOT SIZE1
EX-DATE05/04/2023
News
Press Releases
Financial Reports
Profile
Simply Wall St·14h ago
GeneDx Holdings (WGS) Launches Easy Order As Pediatric Testing Narrative Shapes Valuation
Simply Wall St·4d ago
How Easier Test Ordering Will Impact GeneDx Stock (WGS)
TipRanks·5d ago
GeneDx to introduce Easy Order at AAP 2026
Dow Jones·5d ago
GeneDx Holdings Is Maintained at Buy by Guggenheim
TipRanks·09/22 15:50
GeneDx selloff after CMS news ‘probably too extreme,’ says Craig-Hallum
TipRanks·09/22 14:05
GeneDx falls -5.4%
TipRanks·09/22 13:55
Craig-Hallum sees potential for confusion after CMS fee schedule
TipRanks·09/22 13:00
Craig-Hallum warns CMS Lab Fee proposal may spur confusion across genomics names
Simply Wall St·09/22 12:23
Should Free Rare Disease Testing Require Action From GeneDx (WGS) Investors?
Seeking Alpha·09/21 11:05
Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF
Simply Wall St·09/15 09:25
GeneDx Holdings (WGS) Launches NPC Testing Program Following Collaboration as Valuation Stays In Focus
Same Industry
Name/Symbol
Change%
Price